An Arizona research team is leading an international effort to test a new therapy for advanced melanoma, a deadly skin cancer.

Q: My sister-in-law is 82 years old and was recently diagnosed with melanoma. She has an appointment for treatment in a ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on ...